News

Filter

Current filters:

RegulationRegeneron

1 to 9 of 41 results

Regeneron and Sanofi granted breakthrough designation for dupilumab

Regeneron and Sanofi granted breakthrough designation for dupilumab

25-11-2014

US biotech Regeneron Pharmaceuticals and French pharma major Sanofi have said that the US Food and Drug…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

Sanofi and Regeneron’s dupilumab gets Breakthrough designation from FDA

20-11-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation to French pharma major…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

Bayer/Regeneron’s Eylea approved in Japan for DME

18-11-2014

German pharma major Bayer’s Japanese subsidiary, Bayer Yakuhin, has received approval from the Ministry…

BayerBiotechnologyEyleaJapanOphthalmicsRegeneronRegulation

Regeneron/Bayer Eylea filed for marketing authorization in Japan for macular edema

Regeneron/Bayer Eylea filed for marketing authorization in Japan for macular edema

04-09-2014

American biotech company Regeneron's global development partner for Eylea (aflibercept), Germany's Bayer…

BayerBiotechnologyCentral retinal vein occlusionEyleaJapanMacular degenerationMacular edemaOphthalmicsOphthalmologyRegeneronRegulationVision

Eylea approved for diabetic macular edema in Europe

Eylea approved for diabetic macular edema in Europe

11-08-2014

The European Commission has approved German pharma major Bayer’s Eylea (aflibercept) injection for…

BayerEuropeEyleaOphthalmicsOphthalmologyPharmaceuticalRegeneronRegulation

Sanofi and Regeneron purchase FDA priority voucher for alirocumab

Sanofi and Regeneron purchase FDA priority voucher for alirocumab

31-07-2014

French drug major Sanofi and USA-based biotech firm Regeneron Pharmaceuticals intend to use a US Food…

alirocumabBioMarin PharmaceuticalFranceMajorPharmaceuticalRare diseasesRare pediatric diseasesRegeneronRegeneron PharmaceuticalsRegulationSanofiUSA

Regeneron’s Eylea gains FDA approval for DME

Regeneron’s Eylea gains FDA approval for DME

30-07-2014

The Food and Drug Administration has approved US biotech firm Regeneron Pharmaceuticals’ Eylea (aflibercept)…

BayerBiotechnologyEyleaOphthalmicsRegeneronRegulationUSA

Bayer files for EMA approval of Eylea for macular edema secondary to BRVO

Bayer files for EMA approval of Eylea for macular edema secondary to BRVO

11-06-2014

German pharma major Bayer has submitted an application to the European Medicines Agency seeking marketing…

BayerEuropeEyleaOphthalmicsPharmaceuticalRegeneronRegulation

1 to 9 of 41 results

COMPANY SPOTLIGHT

Menarini

Back to top